•
Mar 31, 2021

Lyell Immunopharma Q1 2021 Earnings Report

Total Revenue
$2.45M
Previous year: $1.26M
+94.7%
EPS
-$3.19
Previous year: -$0.138
+2210.1%
Gross Profit
-$553K
Previous year: $1.26M
-144.0%
Cash and Equivalents
$244M
Free Cash Flow
-$52.8M

Lyell Immunopharma

Lyell Immunopharma